Dr. Juliette Saad, MD

Neurology Spartanburg, SC Female
NPI: 1558441212
Total Payments
$41,094
2022 Payments
$81.11
Companies
39
Transactions
329
Medicare Patients
776
Medicare Billing
$480,377

Payment Breakdown by Category

Other$23,810 (57.9%)
Food & Beverage$6,697 (16.3%)
Consulting$6,089 (14.8%)
Travel$4,460 (10.9%)
Education$38.17 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $23,810 19 57.9%
Food and Beverage $6,697 288 16.3%
Consulting Fee $6,089 7 14.8%
Travel and Lodging $4,460 11 10.9%
Education $38.17 4 0.1%

Top Paying Companies

Company Total Records Latest Year
Mallinckrodt Enterprises LLC $16,086 16 $0 (2019)
Teva Pharmaceuticals USA, Inc. $10,350 24 $0 (2020)
Alexion Pharmaceuticals, Inc. $5,420 18 $0 (2019)
Supernus Pharmaceuticals, Inc. $4,861 68 $0 (2020)
Biogen, Inc. $1,300 44 $0 (2022)
Novartis Pharmaceuticals Corporation $532.15 32 $0 (2020)
EMD Serono, Inc. $482.40 14 $0 (2021)
Genentech USA, Inc. $318.60 18 $0 (2020)
Amgen Inc. $307.61 9 $0 (2020)
Celgene Corporation $221.92 5 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2022 $81.11 1 Biogen, Inc. ($81.11)
2021 $83.93 2 EMD Serono, Inc. ($64.90)
2020 $775.44 35 EMD Serono, Inc. ($210.99)
2019 $7,628 140 Alexion Pharmaceuticals, Inc. ($5,381)
2018 $14,527 91 Mallinckrodt LLC ($6,010)
2017 $17,999 60 Mallinckrodt LLC ($10,035)

All Payment Transactions

329 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
05/11/2022 Biogen, Inc. TYSABRI (Biological), TECFIDERA, VUMERITY Food and Beverage In-kind items and services $81.11 General
Category: Neurology
02/02/2021 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $19.03 General
Category: Neuroscience
01/27/2021 EMD Serono, Inc. — Food and Beverage In-kind items and services $64.90 General
11/18/2020 Biogen, Inc. TYSABRI (Biological), PLEGRIDY, VUMERITY Food and Beverage In-kind items and services $60.04 General
Category: NEUROLOGY
11/17/2020 EMD Serono, Inc. Mavenclad (Drug) Food and Beverage In-kind items and services $74.15 General
Category: Neurology
11/12/2020 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $18.21 General
Category: NEUROSCIENCE
11/05/2020 Teva Pharmaceuticals USA, Inc. AJOVY (Biological) Food and Beverage In-kind items and services $14.28 General
Category: Central Nervous System
10/22/2020 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Food and Beverage Cash or cash equivalent $16.25 General
Category: AED
10/20/2020 Biogen, Inc. — Food and Beverage In-kind items and services $15.81 General
10/01/2020 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $16.86 General
Category: NEUROSCIENCE
09/30/2020 EMD Serono, Inc. Mavenclad (Drug) Food and Beverage In-kind items and services $18.25 General
Category: Neurology
09/29/2020 Amgen Inc. Aimovig (Biological) Food and Beverage In-kind items and services $19.23 General
Category: Neuroscience
09/25/2020 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Education Cash or cash equivalent $14.88 General
Category: Neuroscience
09/25/2020 E.R. Squibb & Sons, L.L.C. ZEPOSIA (Drug) Education Cash or cash equivalent $14.88 General
Category: Neuroscience
09/21/2020 EMD Serono, Inc. Mavenclad (Drug) Food and Beverage In-kind items and services $76.79 General
Category: Neurology
09/17/2020 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $13.07 General
Category: NEUROSCIENCE
09/10/2020 Biogen, Inc. TECFIDERA (Drug), VUMERITY Food and Beverage In-kind items and services $19.19 General
Category: NEUROLOGY
09/03/2020 Supernus Pharmaceuticals, Inc. TROKENDI XR (Drug) Food and Beverage Cash or cash equivalent $18.25 General
Category: AED
08/25/2020 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $14.86 General
Category: NEUROLOGY
08/20/2020 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $17.74 General
Category: Central Nervous System
08/17/2020 EMD Serono, Inc. Mavenclad (Drug) Food and Beverage In-kind items and services $41.80 General
Category: Neurology
08/10/2020 Allergan, Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $14.72 General
Category: NEUROSCIENCE
08/06/2020 Biogen, Inc. TECFIDERA (Drug), VUMERITY Food and Beverage In-kind items and services $14.52 General
Category: NEUROLOGY
07/28/2020 Amgen Inc. Aimovig (Biological) Food and Beverage In-kind items and services $15.38 General
Category: Neuroscience
07/16/2020 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $23.58 General
Category: Neuroscience
123…14»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 2 125 129 $14,538 $6,222
2020 12 651 20,125 $2.0M $474,156
Total Patients
776
Total Services
20,254
Medicare Billing
$480,377
Procedure Codes
14

All Medicare Procedures & Services

14 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 100 104 $10,788 $4,392 40.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 25 25 $3,750 $1,830 48.8%
J2350 Injection, ocrelizumab, 1 mg Office 2020 14 8,400 $1.4M $280,429 20.5%
J2323 Injection, natalizumab, 1 mg Office 2020 11 10,500 $460,110 $128,350 27.9%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 399 921 $132,751 $43,380 32.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 73 80 $13,346 $6,091 45.6%
99205 New patient office or other outpatient visit, typically 60 minutes Office 2020 42 42 $12,602 $5,647 44.8%
96413 Infusion of chemotherapy into a vein up to 1 hour Office 2020 23 63 $37,800 $5,589 14.8%
G0181 Physician supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of c Office 2020 16 24 $3,012 $1,889 62.7%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 11 11 $1,565 $1,147 73.3%
G0180 Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem Office 2020 24 26 $2,106 $1,001 47.5%
G0179 Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp Office 2020 13 13 $1,012 $323.06 31.9%
96375 Injection of different drug or substance into a vein for therapy, diagnosis, or prevention Office 2020 13 26 $1,768 $296.83 16.8%
J1200 Injection, diphenhydramine hcl, up to 50 mg Office 2020 12 19 $34.20 $13.21 38.6%

About Dr. Juliette Saad, MD

Dr. Juliette Saad, MD is a Neurology healthcare provider based in Spartanburg, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558441212.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Juliette Saad, MD has received a total of $41,094 in payments from pharmaceutical and medical device companies, with $81.11 received in 2022. These payments were reported across 329 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($23,810).

As a Medicare-enrolled provider, Saad has provided services to 776 Medicare beneficiaries, totaling 20,254 services with total Medicare billing of $480,377. Data is available for 2 years (2020–2021), covering 14 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Spartanburg, SC
  • Active Since 10/17/2006
  • Last Updated 11/23/2009
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1558441212

Products in Payments

  • ACTHAR (Biological) $16,086
  • COPAXONE (Drug) $10,278
  • OXTELLAR XR (Drug) $4,502
  • TYSABRI (Biological) $1,023
  • TROKENDI XR (Drug) $359.90
  • OCREVUS (Biological) $318.60
  • Aimovig (Biological) $307.61
  • GILENYA (Drug) $279.77
  • Mavenclad (Drug) $210.99
  • Mavenclad (Biological) $195.87
  • Ozanimod (Drug) $179.31
  • TECFIDERA (Drug) $170.72
  • MAYZENT (Drug) $144.39
  • EMGALITY (Drug) $134.09
  • Vimpat (Drug) $114.33
  • INBRIJA (Drug) $109.98
  • Xadago (Drug) $100.94
  • AUBAGIO (Drug) $100.84
  • ZINBRYTA (Biological) $89.65
  • ZEPOSIA (Drug) $72.37

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Spartanburg

Bogdan Gheorghiu, M.d, M.D

Neurology — Payments: $55,400

Neurology $55,400

Carol Kooistra, Md, MD

Neurology — Payments: $28,936

Neurology $28,936

Dr. Gonzalo Pares, M.d, M.D

Neurology — Payments: $10,042

Neurology $10,042

Tonya Frazier, Md, MD

Neurology — Payments: $3,646

Neurology $3,646

Andrea Gil Guevara, M.d, M.D

Neurology — Payments: $2,382

Neurology $2,382

Rowena Desailly-Chanson, Md, MD

Neurology — Payments: $660.38

Neurology $660.38